CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	4 Months Ended	12 Months Ended
	Jan. 31, 2015	Jan. 30, 2016	Sep. 30, 2014	Sep. 30, 2013
Operating Activities
Net income (loss)	$ (17,380)	$ (4,483)	$ 10,497	$ 23,943
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	5,223	17,231	15,197	12,424
Stock-based compensation expense	1,073	2,784	3,747	2,771
Loss on impairment of long-lived assets	4,444	1,662	1,136	786
Loss (gain) on disposal of assets	109	193	(4,031)	528
Loss on extinguishment of debt				9
Grow NJ award benefit		(3,600)
Deferred income tax provision (benefit)	(6,636)	2,020	(2,975)	(3,007)
Amortization of deferred financing costs	66	166	198	203
Decrease (increase) in:
Trade receivables	2,406	(951)	855	727
Inventories	12,652	3,250	(1,865)	2,205
Prepaid expenses and other current assets	142	3,194	(5,511)	(2,708)
Other non-current assets	(59)	(178)	(503)	(54)
Increase (decrease) in:
Accounts payable, accrued expenses and other current liabilities	1,116	(3,675)	5,081	4,058
Deferred rent and other non-current liabilities	675	(1,519)	4,019	268
Net cash provided by operating activities	3,831	16,094	25,845	42,153
Investing Activities
Capital expenditures	(21,098)	(29,272)	(40,185)	(15,059)
Proceeds from sale of property, plant and equipment		35	12,591
Additions to intangible assets	(768)	(163)	(1,950)	(963)
Net cash used in investing activities	(21,866)	(29,400)	(29,544)	(16,022)
Financing Activities
(Decrease) increase in cash overdrafts	(5,384)	(277)	3,081	1,278
Increase in line of credit borrowings		28,400
Proceeds from long-term debt	15,000
Repayment of long-term debt		(2,801)		(15,257)
Deferred financing costs paid		(157)		(927)
Withholding taxes on stock-based compensation paid in connection with repurchase of common stock	(123)	(127)	(2,178)	(725)
Cash dividends paid	(2,717)	(11,026)	(10,772)	(9,799)
Proceeds from exercise of stock options	29	69	271	744
Excess tax benefit from exercise of stock options and restricted stock vesting			1,319	760
Net cash provided by (used in) financing activities	6,805	14,081	(8,279)	(23,926)
Effect of exchange rate changes on cash and cash equivalents	(1)	(8)	3	(26)
Net Increase (Decrease) in Cash and Cash Equivalents	(11,231)	767	(11,975)	2,179
Cash and Cash Equivalents, Beginning of Period	12,580	1,349	24,555	22,376
Cash and Cash Equivalents, End of Period	$ 1,349	$ 2,116	$ 12,580	$ 24,555